Antonio Calles Blanco
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (NCT04358237) | Antonio Calles Blanco | 2020-09-21 |
Track Antonio Calles Blanco automatically
Every clearance here is in the API, with alerts when new ones post.